Bio ReFine.jpg
Boaz-Shenhav-Bio-Refine.jpg
Boaz Shenhav
CEO

Bio ReFine has developed a unique endovascular annuloplasty remodeling system, without an implant, for the repair of the mitral and tricuspid heart valves.

The innovative technology will offer treatment to a huge population that is not currently treated due to the high risk of open surgery.

The implantless solution offers multiple advantages: significantly easier regulation, it uses a standard endovascular approach, the procedure is safe, implant-free, repeatable and does not prevent ancillary procedures.

stripBIG-01.jpg

PORTFOLIO

 
icon-08.png

DEVICES

icon-09.png
icon-07.png

PHARMA & BIOTECH

icon-10.png
icon-06.png

PHARMA & BIOTECH

icon-11.png